Zaher Nahle

From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
Jump to: navigation, search
Source: Solve ME/CFS Initiative solvecfs.org

Zaher Nahle, PhD, MPA, is a Lebanese-American scientist and executive with interdisciplinary training in administration and biomedical research. He previously served as Chief Scientific Officer (CSO) and Vice President for Research at Solve ME/CFS Initiative (SMCI).[1] He is now Chief Executive Officer of the Arthritis National Research Foundation, ANRF (www.Curearthritis.org).

Education[edit | edit source]

  • Bachelor's degree in Chemistry from American University of Beirut (1995)
  • Master in Public Administration from Harvard University’s John F. Kennedy School of Government (2013)
  • PhD in physiology and biophysics from Cold Spring Harbor Laboratory and Stony Brook University (2003)
  • Post-doctoral fellowships at both Harvard and StonyBrook (2003-04)

Career[edit | edit source]

In the first part of his career, Dr. Nahle served as an Assistant Professor of Neurosurgery and Cancer Biology at Vanderbilt University Medical Center[2] and founded a nonprofit organization focused on the disability agenda with a classmate while studying at Harvard.

From June 2015 to February 2018, Dr. Nahle served as Chief Scientific Officer (CSO) and Vice President for Research at Solve ME/CFS Initiative (SMCI)[1] where he oversaw a research and scientific portfolio that included a peer-review grant program for external investigators, specialized biobanking and patient registry platforms as well as numerous medical education initiatives for patients and healthcare professionals. He also directed a specialized investment program with medical centers, government agencies and industry partners to accelerate the discovery process in the ME/CFS research.

He is now Chief Executive Officer of the Arthritis National Research Foundation, ANRF (www.Curearthritis.org). ANRF has earned a four-star (i.e. top) rating from Charity Navigator nine years in a row,[3] and is dedicated to funding innovative research to understand the causes of osteoarthritis, rheumatoid arthritis, lupus, juvenile arthritis, fibromyalgia and related autoimmune and inflammatory conditions.

Dr. Nahle often speaks at international conferences and serves on committees at US federal agencies, including the NIH and the CDC. His background includes cancer biology, high-throughput technologies, diabetes, and ME/CFS. His work is featured in journals like Science and Nature. He was an awardee of the American Heart Association (AHA) and the Department of Defense (DoD) and a Mason fellow at Harvard's John F. Kennedy School of Government.

Awards[edit | edit source]

  • Department of Defense Breast Cancer Fellowship Award - Congressionally Directed Medical Research Programs (2000)
  • American Heart Association (AHA) career development award BGIA - Outstanding score (2008)
  • National Priorities Research Program - Qatar Foundation (2010)
  • American Cancer Society (ACS) Scholar (pay if) - Outstanding score (2011)
  • Harvard Kennedy School, Merit Scholarship (2013)
  • Robert Wood Johnson Foundation PEER White Label Award - for the establishment and implementation of a national Patient Registry and Electronic Health Information (EHI) system for ME/CFS (2016) [4]

National committees and advocacy[edit | edit source]


Interviews & Talks[edit | edit source]

Open Letter to The Lancet[edit | edit source]

Two open letters to the editor of The Lancet urged the editor to commission a fully independent review of the PACE trial, which the journal had published in 2011. In 2016, Dr. Nahle, along with 41 colleagues in the ME/CFS field, signed the second letter.

Blog Posts and Editorials (selected)[edit | edit source]

2015[edit | edit source]

2016[edit | edit source]

2017[edit | edit source]

2018[edit | edit source]

Online presence[edit | edit source]

References[edit | edit source]

  1. 1.01.1 https://www.linkedin.com/in/zahernahle/
  2. https://www.linkedin.com/in/zahernahle
  3. "Best Charities | Transparency and Accountability". Arthritis Research | Arthritis National Research Foundation. Retrieved Jan 30, 2019. 
  4. http://solvecfs.org/smci-receives-rwjf-award
  5. "Complete Myalgic Encephalomyelitis/Chronic Fatigue Syndrome CDE Roster". NIH. Retrieved Oct 11, 2019. 
  6. https://www.commondataelements.ninds.nih.gov/Doc/MECFS/Baseline_Covariate_Information_Subgroup_Summary.pdf
  7. Friedman, Kenneth; Bateman, Lucinda; Bested, Alison C.; Nahle, Zaher (Aug 2019). "Editorial: Advances in ME/CFS Research and Clinical Care". Frontiers in Pediatrics. doi:10.3389/fped.2019.00370. 
  8. Johnson, Cort (Nov 19, 2015). ""Get Your Motor Running" - Zaher Nahle Takes on Chronic Fatigue Syndrome". Health Rising. Retrieved Sep 3, 2019. 
  9. "ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative". PMWC Precision Medicine World Conference. Retrieved Sep 3, 2019. 
  10. "ME/Chronic Fatigue Syndrome Takes Center Stage on First Afternoon of Personalized Medicine World Conference (PMWC) 2017 at Duke | www.bioquicknews.com". www.bioquicknews.com. Retrieved Sep 3, 2019. 
  11. "ME/CFS: The Mysterious Illness Science Has Yet to Unravel Session Chair: Zaher Nahle, Solve ME/CFS Initiative". Precision Medicine World Conference 2017 Duke. Retrieved Sep 3, 2019. 
  12. http://solvecfs.org/wp-content/uploads/2017/06/BRMEC7-Colloquium-2017-Welcome-to-London.pdf
  13. Chronic Fatigue Syndrome: a disease hidden in plain sight | White House Chronicle, retrieved Sep 3, 2019 

Myalgic encephalomyelitis or chronic fatigue syndrome, often used when both illnesses are considered the same.

The information provided at this site is not intended to diagnose or treat any illness.
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history.